Resultados de procura - Michiel de Maaker
- Mostrando 1 - 5 Resultados de 5
-
1
Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer por Iris Nederlof, Davide De Bortoli, Yacine Barèche, Bastien Nguyen, Michiel de Maaker, Gerrit K. Hooijer, Laurence Buisseret, Marleen Kok, Marcel Smid, Gert G. G. M. Van den Eynden, Arie B. Brinkman, Jan Hudeček, Jan Köster, Christos Sotiriou, Denis Larsimont, John W.M. Martens, Marc J. van de Vijver, Hugo M. Horlings, Roberto Salgado, Elia Biganzoli, Christine Desmedt
Publicado 2019Artigo -
2
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial por Leonie Voorwerk, Olga I. Isaeva, Hugo M. Horlings, Sara Balduzzi, Maksim Chelushkin, Noor A. M. Bakker, Elisa Champanhet, Hannah Garner, Karolina Sikorska, Claudette E. Loo, Inge Kemper, Ingrid A.M. Mandjes, Michiel de Maaker, Jasper van Geel, Jorianne Boers, Maaike de Boer, Roberto Salgado, Marloes G. J. van Dongen, Gabe S. Sonke, Karin E. de Visser, Ton N. Schumacher, Christian U. Blank, Lodewyk F.A. Wessels, Agnes Jager, Vivianne C. G. Tjan‐Heijnen, Carolien P. Schröder, Sabine C. Linn, Marleen Kok
Publicado 2023Artigo -
3
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition por Noah F. Greenwald, Iris Nederlof, C. H. Sowers, Daisy Yi Ding, Seongyeol Park, Alex Kong, Kathleen E. Houlahan, Sricharan Reddy Varra, Manon de Graaf, Veerle Geurts, Candace C. Liu, Jolene S. Ranek, Leonie Voorwerk, Michiel de Maaker, Adam Kagel, Erin McCaffrey, Aziz Khan, Christine Y. Yeh, Christine Camacho Fullaway, Zumana Khair, Yunhao Bai, Hadeesha Piyadasa, Tyler Risom, Alea Delmastro, Felix J. Hartmann, Lise Mangiante, Cristina Sotomayor-Vivas, Ton N. Schumacher, Zhicheng Ma, Marc Bossé, Marc J. van de Vijver, Robert Tibshirani, Hugo M. Horlings, Christina Curtis, Marleen Kok, Michael Angelo
Publicado 2025Pré-impressão -
4
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial por Iris Nederlof, Olga I. Isaeva, Manon de Graaf, R. Gielen, Noor A. M. Bakker, A.L. Rolfes, Hannah Garner, Bram Boeckx, Joleen J.H. Traets, Ingrid A.M. Mandjes, Michiel de Maaker, Thomas Van Brussel, Maksim A. Chelushkin, Elisa Champanhet, Marta López‐Yurda, Koen Van de Vijver, José G. van den Berg, Ingrid Hofland, Natasja Klioueva, Ritse M. Mann, Claudette E. Loo, Frederieke van Duijnhoven, Victoria Skinner, Sylvia Luykx, Emile D. Kerver, Ekaterina Kalashnikova, Marloes G. J. van Dongen, Gabe S. Sonke, Sabine C. Linn, Christian U. Blank, Karin E. de Visser, Roberto Salgado, Lodewyk F.A. Wessels, Caroline A. Drukker, Ton N. Schumacher, Hugo M. Horlings, Diether Lambrechts, Marleen Kok
Publicado 2024Artigo -
5
Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer por Esther H. Lips, Tapsi Kumar, Anargyros Megalios, Lindy L. Visser, Michael Sheinman, Angelo Fortunato, Vandna Shah, Marlous Hoogstraat, Emi Sei, Diego Mallo, Maria Roman-Escorza, Ahmed A. Ahmed, Mingchu Xu, Alexandra W. van den Belt‐Dusebout, Wim Brugman, Tod D. Casasent, Karen Clements, Helen Davies, Liping Fu, Anita Grigoriadis, Timothy Hardman, Lorraine King, Marielle Krete, Petra Kristel, Michiel de Maaker, Carlo C. Maley, Jeffrey R. Marks, Brian A. Menegaz, Lennart Mulder, Frank Nieboer, Salpie Nowinski, Sarah E. Pinder, Jelmar Quist, Carolina Salinas-Souza, Michael Schaapveld, Marjanka K. Schmidt, Abeer M. Shaaban, Rana Shami, Mathini Sridharan, John H. Zhang, Hilary Stobart, Deborah Collyar, Serena Nik‐Zainal, Lodewyk F.A. Wessels, E. Shelley Hwang, Nicholas E. Navin, P. Andrew Futreal, P. Andrew Futreal, E. Shelley Hwang, Jos Jonkers, Jacco, Fariba Behbod, Daniel Rea, Proteeti Bhattacharjee, Donna Pinto, Ellen Verschuur, Marja van Oirsouw, Alastair M. Thompson, Jelle Wesseling, Elinor J. Sawyer
Publicado 2022Artigo
Ferramentas de procura:
Materias Relacionadas
Breast cancer
Cancer
Immune system
Immunology
Medicine
Oncology
Biology
Cancer research
Immunotherapy
Internal medicine
Chemotherapy
Clinical trial
Immune checkpoint
Nivolumab
Triple-negative breast cancer
Atezolizumab
Blockade
CD20
CD8
Carboplatin
Cisplatin
Clinical endpoint
Composition (language)
Computational biology
Computer science
Concordance
Ductal carcinoma
FOXP3
Genetics
H&E stain